James Dickinson

James Dickinson has over 25 years of work experience in the pharmaceutical industry. James currently serves as the Head of Clinical Pharmacology and Pharmacokinetics at InflaRx N.V. since October 2021. Prior to this, they worked as the Head of Early Clinical Development at bioeq GmbH from June 2018 to September 2021. From March 2014 to May 2018, they held the position of Vice President, Global Head of Clinical Services at Nuvisan Pharma Services. James also worked at Astellas Pharma from October 2001 to February 2014, first as a Manager of Pharmacokinetics and later as an Associate Director of Global Clinical Pharmacology and Exploratory Development. James began their career in the industry as a CTA/CRA at Fujisawa from July 1996 to September 2001.

James Dickinson has a BA in English from the University of Nottingham, and they have also completed a BSc in Biology and an MSc in Clinical Pharmacology from The Open University.